LuciCyp

Description

COMPOSITION:

Each LuciCyp tablet contains:50 mg cyproterone acetate.

INDICATION:

1.Indications in females

Severe signs of androgenisation, e.g. very severe hirsutism, androgen-dependent severe loss of scalp hair eventually resulting in baldness (severe androgenic alopecia), often attended by severe forms of acne and/ or seborrhoea.

2.Indications in males

Reduction of drives in sexual deviations.

Anti-androgen treatment in inoperable carcinoma of the prostate.

DOSAGE AND USE:

The usual dose is 1 tablet twice a day. Once the desired effect is achieved, your dose may be gradually lowered.

Take the tablet after your morning and evening meals.

The maximum daily dose is 300 mg.

STORAGE:

Store at or below 30°C and in a dry place.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children.Do not administer LuciCyp during Pregnancy and Lactation.